QQQ   389.66 (-0.14%)
AAPL   189.20 (-0.63%)
MSFT   379.04 (-0.96%)
META   332.48 (-1.92%)
GOOGL   135.05 (-1.57%)
AMZN   146.22 (-0.55%)
TSLA   243.97 (-1.11%)
NVDA   482.05 (+0.80%)
NIO   7.16 (-0.69%)
BABA   74.75 (-2.59%)
AMD   123.61 (+1.31%)
T   16.29 (+0.68%)
F   10.60 (+2.22%)
MU   76.55 (+0.56%)
CGC   0.56 (+3.87%)
GE   118.84 (+-0.01%)
DIS   92.45 (-0.05%)
AMC   7.15 (+6.72%)
PFE   30.03 (+1.15%)
PYPL   57.93 (-0.92%)
XOM   102.08 (-1.75%)
QQQ   389.66 (-0.14%)
AAPL   189.20 (-0.63%)
MSFT   379.04 (-0.96%)
META   332.48 (-1.92%)
GOOGL   135.05 (-1.57%)
AMZN   146.22 (-0.55%)
TSLA   243.97 (-1.11%)
NVDA   482.05 (+0.80%)
NIO   7.16 (-0.69%)
BABA   74.75 (-2.59%)
AMD   123.61 (+1.31%)
T   16.29 (+0.68%)
F   10.60 (+2.22%)
MU   76.55 (+0.56%)
CGC   0.56 (+3.87%)
GE   118.84 (+-0.01%)
DIS   92.45 (-0.05%)
AMC   7.15 (+6.72%)
PFE   30.03 (+1.15%)
PYPL   57.93 (-0.92%)
XOM   102.08 (-1.75%)
QQQ   389.66 (-0.14%)
AAPL   189.20 (-0.63%)
MSFT   379.04 (-0.96%)
META   332.48 (-1.92%)
GOOGL   135.05 (-1.57%)
AMZN   146.22 (-0.55%)
TSLA   243.97 (-1.11%)
NVDA   482.05 (+0.80%)
NIO   7.16 (-0.69%)
BABA   74.75 (-2.59%)
AMD   123.61 (+1.31%)
T   16.29 (+0.68%)
F   10.60 (+2.22%)
MU   76.55 (+0.56%)
CGC   0.56 (+3.87%)
GE   118.84 (+-0.01%)
DIS   92.45 (-0.05%)
AMC   7.15 (+6.72%)
PFE   30.03 (+1.15%)
PYPL   57.93 (-0.92%)
XOM   102.08 (-1.75%)
QQQ   389.66 (-0.14%)
AAPL   189.20 (-0.63%)
MSFT   379.04 (-0.96%)
META   332.48 (-1.92%)
GOOGL   135.05 (-1.57%)
AMZN   146.22 (-0.55%)
TSLA   243.97 (-1.11%)
NVDA   482.05 (+0.80%)
NIO   7.16 (-0.69%)
BABA   74.75 (-2.59%)
AMD   123.61 (+1.31%)
T   16.29 (+0.68%)
F   10.60 (+2.22%)
MU   76.55 (+0.56%)
CGC   0.56 (+3.87%)
GE   118.84 (+-0.01%)
DIS   92.45 (-0.05%)
AMC   7.15 (+6.72%)
PFE   30.03 (+1.15%)
PYPL   57.93 (-0.92%)
XOM   102.08 (-1.75%)

InnovAge Stock Price, News & Analysis (OTCMKTS:INNV)

$5.76
-0.04 (-0.69%)
(As of 11/28/2023 ET)
Compare
Today's Range
$5.64
$6.10
50-Day Range
$5.18
$7.01
52-Week Range
$5.04
$8.15
Volume
15,077 shs
Average Volume
36,219 shs
Market Capitalization
$782.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

InnovAge MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
38.9% Upside
$8.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.25) to ($0.05) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.46 out of 5 stars


INNV stock logo

About InnovAge Stock (OTCMKTS:INNV)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

INNV Stock Price History

INNV Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Earnings Preview: InnovAge Holding
INNVInnovAge Holding Corp.
The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
Recap: InnovAge Holding Q3 Earnings
What Wall Street expects from InnovAge's earnings
See More Headlines
Receive INNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2023
Today
11/29/2023
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Medical Care Facilities
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:INNV
Previous Symbol
NASDAQ:INNV
Fax
N/A
Employees
2,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$9.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+38.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-6,520,000.00
Pretax Margin
-7.63%

Debt

Sales & Book Value

Annual Sales
$699.35 million
Cash Flow
$0.09 per share
Book Value
$2.50 per share

Miscellaneous

Free Float
135,311,000
Market Cap
$782.70 million
Optionable
Not Optionable
Beta
0.09
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Patrick Blair (Age 52)
    President & CEO
    Comp: $1.51M
  • Ms. Nicole D'Amato (Age 44)
    Chief Legal Officer & Corporate Secretary
    Comp: $678.76k
  • Dr. Richard A. Feifer FACP (Age 56)
    M.D., M.P.H., Chief Medical Officer
    Comp: $588.97k
  • Mr. Edward Moore Kennedy Jr. (Age 62)
    J.D., Independent Director
    Comp: $100k
  • Hon. Marilyn Barbour Tavenner M.H.A. (Age 62)
    R.N., Independent Director
    Comp: $120k
  • Mr. Benjamin Crowninshield Adams (Age 59)
    Chief Financial Officer
  • Ms. Christine Bent (Age 53)
    Chief Operations Officer
  • Ms. Cara Babachicos
    Chief Information Officer
  • Mr. Ryan Kubota
    Director of Investor Relations
  • Ms. Olivia Patton
    Chief Compliance Officer














INNV Stock Analysis - Frequently Asked Questions

Should I buy or sell InnovAge stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InnovAge in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" INNV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INNV, but not buy additional shares or sell existing shares.
View INNV analyst ratings
or view top-rated stocks.

What is InnovAge's stock price target for 2024?

2 analysts have issued 1 year target prices for InnovAge's stock. Their INNV share price targets range from $7.00 to $9.00. On average, they anticipate the company's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 38.9% from the stock's current price.
View analysts price targets for INNV
or view top-rated stocks among Wall Street analysts.

How have INNV shares performed in 2023?

InnovAge's stock was trading at $7.18 at the start of the year. Since then, INNV shares have decreased by 19.8% and is now trading at $5.76.
View the best growth stocks for 2023 here
.

How were InnovAge's earnings last quarter?

InnovAge Holding Corp. (OTCMKTS:INNV) issued its quarterly earnings results on Tuesday, November, 7th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.04. The company had revenue of $182.49 million for the quarter, compared to analysts' expectations of $176.81 million. InnovAge had a negative trailing twelve-month return on equity of 13.04% and a negative net margin of 6.17%.

What other stocks do shareholders of InnovAge own?
How do I buy shares of InnovAge?

Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:INNV) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -